LP
LSBPW

LMR Partners’s LakeShore Biopharma Warrants LSBPW Stock Holding History

LMR Partners’s Portfolio LSBPW Stock Details LSBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,052,461
Closed -$69.6K – 1678
2024
Q3 		$69.6K Buy
+1,052,461
New +$66.4K ﹤0.01% 1059

Other funds holding LSBPW

HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

LMR Partners's LSBPW Position: Q3 2025 in Review

LMR Partners sold out of LakeShore Biopharma Warrants (LSBPW) in Q3 2025, closing a stake of 1,052,461 shares — an estimated $42K sold.

LMR Partners first reported a position in LSBPW in Q1 2023 and held it in 9 quarters. The position peaked at $1.68M in Q1 2023. 3 funds tracked by Wall St. Rank hold LSBPW as of Q3 2025.

  • LMR Partners reported no remaining LakeShore Biopharma Warrants position as of Q3 2025 after selling out during the quarter.
  • LMR Partners sold 1,052,461 LakeShore Biopharma Warrants shares in Q3 2025, an estimated $42K.
  • LMR Partners first reported a position in LakeShore Biopharma Warrants in Q1 2023 and held it in 9 quarters.
  • LMR Partners's LakeShore Biopharma Warrants position peaked at $1.68M in Q1 2023.
  • 3 funds tracked by Wall St. Rank held LakeShore Biopharma Warrants as of Q3 2025.

Based on LMR Partners's 13F filing for Q3 2025, filed 14 Nov 2025.